Altimmune To Report Results Of Obesity Treatment On Sept. 28
Published
Sep 27 2021 at 9:02 PM GMT
Key
Points
Points
- (RTTNews) - Biopharmaceutical company Altimmune, Inc.
- (ALT) on Monday announced that the company will report results from a Phase 1 clinical trial of ALT-801 in overweight and obese subjects.
- The company said it will discuss the results in a pre-market press release, conference call and webcast on September 28 at 8:30 a m ET.
Trending
Stats
- Published Sep 27, 2021 9:02 PM GMT